ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Diabetic Kidney Disease Collaborative (DKD-C)

Diabetic Kidney Disease Coallition

DKD-C

Working Together to Address the Urgent and Unmet Needs in the Diagnosis and Treatment of People with Diabetic Kidney Disease

Diabetic Kidney Disease Strategy Conference: Implementing New Diabetic Kidney Disease Treatments – Time to Act

Diabetic Kidney Disease Strategy Conference: Implementing New Diabetic Kidney Disease Treatments – Time to Act

The American Society of Nephrology's (ASN's) Diabetic Kidney Disease Collaborative (DKD-C) conducted the second in a series of three strategy conferences on April 20, 2021. Conference participants strategized on how nephrologists and primary care physicians can work together to ensure the implementation of new diabetic kidney disease therapies, such as SGLT2 inhibitors.

  • Recorded Tuesday, April 20, 2021

Recording »Slides »Bios »

New Approaches to Transform Outcomes for Kidney Disease and Heart Disease in Patients with Diabetes

Diabetic Kidney Disease Virtual Roundtable Series: New Approaches to Transform Outcomes for Kidney Disease and Heart Disease in Patients with Diabetes

Clinical experts will review the latest guidelines for both kidney disease and heart disease, and discuss the most recent trials and promising therapies. A roundtable of experts from nephrology, cardiology, and endocrinology will consider implications for diabetes, kidney and heart disease treatment in 2021. Topics presented include:

  • Evolving Landscape For Diabetic Kidney Disease
  • Kidney Disease Guideline Overview
  • Cardiovascular Disease Guideline Overview
    • Recorded Thursday, December 10, 2020

    Recording »Slides »Bios »

    Goal-Directed Medical Therapies for Patients with Diabetic Kidney Disease

    Diabetic Kidney Disease Virtual Roundtable Series: Goal-Directed Medical Therapies for Patients with Diabetic Kidney Disease

    Leading experts in the care of individuals with diabetic kidney disease (DKD) describe the new standard of care for DKD, discuss the clinical indications for SGLT2 inhibitors, and consider payment issues associated with new therapies. The session concludes with a roundtable discussion of key questions, including those submitted by the videoconference participants. Topics presented include:

  • What is The Standard of Care for Diabetic Kidney Disease?
  • Safely and Effectively Prescribing SGLT2 Inhibitors
  • Paying for New Therapies
  • The DAPA-CKD Study
    • Recorded Tuesday, September 29, 2020

    Recording »Slides »Bios »

    Management of Diabetes & Kidney Disease through COVID-19

    Diabetic Kidney Disease Virtual Roundtable Series: Management of Diabetes & Kidney Disease through COVID-19

    Details the care needs and the patient experience managing diabetes and kidney disease during the COVID-19 pandemic. Outlines frequent patient concerns, and provide strategies for maintaining health. Topics presented include:

  • Population Susceptibility To Diabetes
  • Diabetes and Kidney Disease during COVID-19
  • COVID-19 and DKD Management: A Personal Journey
  • Coordinating DKD Care: Who Takes Care Of My Diabetes, And Who Takes Care Of My Kidneys?
    • Recorded Tuesday, August 18, 2020

    Recording »Slides »Bios »

    Why Should I Join A Clinical Trail? »

    Diabetes Tools

    DKD-C Task Force

  • Katherine R. Tuttle, MD, FASN- DKD-C Task Force Chair
  • Frank C. Brosius III, MD
  • David Cherney, PhD, MD
  • Patrick O. Gee, Sr., PhD
  • Raymond C. Harris, MD, FASN
  • Alan S. Kliger, MD
  • Susan E. Quaggin, MD, FASN
    • Posted April 7, 2022